• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM56 通过抑制 HBV 核心启动子活性来影响 HBV 感染和复制。

TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity.

机构信息

Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.

Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing, 100089, China.

出版信息

Antiviral Res. 2022 Nov;207:105406. doi: 10.1016/j.antiviral.2022.105406. Epub 2022 Sep 7.

DOI:10.1016/j.antiviral.2022.105406
PMID:36084850
Abstract

Members of the tripartite motif (TRIM) protein family strongly induced by interferons (IFNs) are parts of the innate immune system with antiviral activity. However, it is still unclear which TRIMs could play important roles in hepatitis B virus (HBV) inhibition. Here, we identified that TRIM56 expression responded in IFN-treated HepG2-NTCP cells and HBV-infected liver tissues, which was a potent IFN-inducible inhibitor of HBV replication. Mechanistically, TRIM56 suppressed HBV replication via its Ring and C-terminal domain. C-terminal domain was essential for TRIM56 translocating from cytoplasm to nucleus during HBV infection. Further analysis revealed that TRIM56's Ring domain targeted IκBα for ubiquitination. This modification induced phosphorylation of p65, which subsequently inhibited HBV core promoter activity, resulting in the inhibition of HBV replication. The p65 was found to be necessary for NF-κB signal pathway to inhibit HBV replication. We verified our findings using HepG2-NTCP and primary human hepatocytes. Our findings reveal that TRIM56 is a critical antiviral immune effector and exerts an anti-HBV activity via NF-κB signal pathway, which is essential for inhibiting transcription of HBV covalently closed circular DNA.

摘要

干扰素(IFNs)强烈诱导的三聚体基序(TRIM)蛋白家族成员是具有抗病毒活性的先天免疫系统的一部分。然而,目前仍不清楚哪些 TRIM 蛋白可以在乙型肝炎病毒(HBV)抑制中发挥重要作用。在这里,我们发现 TRIM56 在 IFN 处理的 HepG2-NTCP 细胞和 HBV 感染的肝组织中表达,这是一种有效的 IFN 诱导的 HBV 复制抑制剂。在机制上,TRIM56 通过其环和 C 末端结构域抑制 HBV 复制。C 末端结构域对于 TRIM56 在 HBV 感染期间从细胞质向核内转移至关重要。进一步的分析表明,TRIM56 的环结构域靶向 IκBα 进行泛素化。这种修饰诱导 p65 的磷酸化,从而抑制 HBV 核心启动子活性,导致 HBV 复制的抑制。发现 p65 对于 NF-κB 信号通路抑制 HBV 复制是必需的。我们使用 HepG2-NTCP 和原代人肝细胞验证了我们的发现。我们的研究结果表明,TRIM56 是一种关键的抗病毒免疫效应因子,通过 NF-κB 信号通路发挥抗 HBV 活性,这对于抑制 HBV 共价闭合环状 DNA 的转录至关重要。

相似文献

1
TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity.TRIM56 通过抑制 HBV 核心启动子活性来影响 HBV 感染和复制。
Antiviral Res. 2022 Nov;207:105406. doi: 10.1016/j.antiviral.2022.105406. Epub 2022 Sep 7.
2
Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.干扰素诱导的MX2是乙肝病毒复制的宿主限制因子。
J Hepatol. 2020 May;72(5):865-876. doi: 10.1016/j.jhep.2019.12.009. Epub 2019 Dec 18.
3
Tripartite Motif-Containing Protein 65 (TRIM65) Inhibits Hepatitis B Virus Transcription.三结构域蛋白 65(TRIM65)抑制乙型肝炎病毒转录。
Viruses. 2024 May 31;16(6):890. doi: 10.3390/v16060890.
4
Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.决定TRIM56对黄病毒和冠状病毒抗病毒活性的重叠且独特的分子决定因素。
J Virol. 2014 Dec;88(23):13821-35. doi: 10.1128/JVI.02505-14. Epub 2014 Sep 24.
5
The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.TRIM56的C末端尾巴通过阻碍病毒RNA合成来决定对甲型和乙型流感病毒的抗病毒限制。
J Virol. 2016 Apr 14;90(9):4369-4382. doi: 10.1128/JVI.03172-15. Print 2016 May.
6
TRIM56 overexpression restricts porcine epidemic diarrhoea virus replication in Marc-145 cells by enhancing TLR3-TRAF3-mediated IFN-β antiviral response.TRIM56 过表达通过增强 TLR3-TRAF3 介导的 IFN-β 抗病毒反应来限制 Marc-145 细胞中猪流行性腹泻病毒的复制。
J Gen Virol. 2022 May;103(5). doi: 10.1099/jgv.0.001748.
7
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.HBV 绕过先天免疫反应,不能保护 HCV 免受干扰素的抗病毒活性。
Gastroenterology. 2018 May;154(6):1791-1804.e22. doi: 10.1053/j.gastro.2018.01.044. Epub 2018 Feb 1.
8
Key roles for phosphorylation and the Coiled-coil domain in TRIM56-mediated positive regulation of TLR3-TRIF-dependent innate immunity.磷酸化和卷曲螺旋结构域在 TRIM56 介导的 TLR3-TRIF 依赖性先天免疫的正向调控中的关键作用。
J Biol Chem. 2024 May;300(5):107249. doi: 10.1016/j.jbc.2024.107249. Epub 2024 Mar 29.
9
Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.乙型肝炎 e 抗原通过中断 NEMO 的 K63 链接泛素化来抑制 NF-κB 活性。
J Virol. 2019 Jan 4;93(2). doi: 10.1128/JVI.00667-18. Print 2019 Jan 15.
10
TRIM56-mediated production of type I interferon inhibits intracellular replication of .TRIM56 介导的 I 型干扰素产生抑制. 的细胞内复制。
Microbiol Spectr. 2024 Apr 2;12(4):e0369523. doi: 10.1128/spectrum.03695-23. Epub 2024 Feb 15.

引用本文的文献

1
Vesicle-associated membrane protein 5 is an intrinsic defense factor for embryonic stem cells against coronaviruses.囊泡相关膜蛋白5是胚胎干细胞对抗冠状病毒的一种内在防御因子。
Nat Commun. 2025 Jul 7;16(1):6241. doi: 10.1038/s41467-025-61655-8.
2
TRIM56 enhances adenoviral E1A steady state to improve oncolytic adenovirus therapy efficacy.TRIM56增强腺病毒E1A的稳态以提高溶瘤腺病毒治疗效果。
J Virol. 2025 Jul 22;99(7):e0004125. doi: 10.1128/jvi.00041-25. Epub 2025 Jun 3.
3
Emerging Roles of TRIM56 in Antiviral Innate Immunity.TRIM56在抗病毒天然免疫中的新作用
Viruses. 2025 Jan 7;17(1):72. doi: 10.3390/v17010072.
4
HBx Facilitates Drug Resistance in Hepatocellular Carcinoma via CD133-regulated Self-renewal of Liver Cancer Stem Cells.乙肝病毒X蛋白通过CD133调控的肝癌干细胞自我更新促进肝细胞癌的耐药性。
J Clin Transl Hepatol. 2025 Jan 28;13(1):15-24. doi: 10.14218/JCTH.2024.00259. Epub 2024 Nov 25.
5
HDAC6 deacetylates TRIM56 to negatively regulate cGAS-STING-mediated type I interferon responses.组蛋白去乙酰化酶6使TRIM56去乙酰化,从而负向调控环鸟苷酸-腺苷酸合成酶-干扰素基因刺激蛋白介导的I型干扰素反应。
EMBO Rep. 2025 Feb;26(3):720-747. doi: 10.1038/s44319-024-00358-5. Epub 2025 Jan 2.
6
Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation.中医治疗慢性乙型肝炎:信号通路调控机制
Heliyon. 2024 Oct 12;10(20):e39176. doi: 10.1016/j.heliyon.2024.e39176. eCollection 2024 Oct 30.
7
LncRNA PVT1 induces mitochondrial dysfunction of podocytes via TRIM56 in diabetic kidney disease.长链非编码 RNA PVT1 通过 TRIM56 诱导糖尿病肾病足细胞线粒体功能障碍。
Cell Death Dis. 2024 Sep 30;15(9):697. doi: 10.1038/s41419-024-07107-5.
8
TRIMming down Flavivirus Infections.修剪下调 flavivirus 感染。
Viruses. 2024 Aug 6;16(8):1262. doi: 10.3390/v16081262.
9
The Role of Tripartite Motif Family Proteins in Chronic Liver Diseases: Molecular Mechanisms and Therapeutic Potential.三部分基序家族蛋白在慢性肝脏疾病中的作用:分子机制和治疗潜力。
Biomolecules. 2024 Aug 21;14(8):1038. doi: 10.3390/biom14081038.
10
Interleukin 27, Similar to Interferons, Modulates Gene Expression of Tripartite Motif (TRIM) Family Members and Interferes with Mayaro Virus Replication in Human Macrophages.白细胞介素 27,类似于干扰素,调节三肽基结构域(TRIM)家族成员的基因表达,并干扰人巨噬细胞中马亚罗病毒的复制。
Viruses. 2024 Jun 20;16(6):996. doi: 10.3390/v16060996.